PPAR- γ impairment alters peroxisome functionality in primary astrocyte cell cultures

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Peroxisomes protect glial cells from hydrogen peroxide (H2O2) damage, and their impairment causes nervous lesions.
• Peroxisome-Proliferator-Activated Receptor gamma (PPAR-γ) agonists show potential as neuroprotective agents.
• The specific role of PPAR-γ in neurodegenerative pathophysiology and its connection to peroxisomal function remain unclear.

Purpose of the Study:

• To investigate the impact of PPAR-γ modulation on peroxisomal function and antioxidant defenses in astrocytes.
• To elucidate the role of PPAR-γ in maintaining catalase activity and overall cellular antioxidant capacity.

Main Methods:

• Primary rat astrocyte cell cultures were treated with PPAR-γ agonists (rosiglitazone) and antagonists (GW9662, G3335).
• Enzyme activity (catalase, glutathione reductase) and gene expression were assessed.
• Specific PPAR-α target genes and mitochondrial enzymes were monitored for alterations.

Main Results:

• PPAR-γ inhibition (GW9662, G3335) dose-dependently decreased catalase activity in astrocytes.
• Catalase functionality recovered with time and was restored by the PPAR-γ agonist rosiglitazone.
• G3335 also reduced glutathione reductase expression, indicating compromised glutathione regeneration.
• PPAR-γ inhibition did not affect PPAR-α target genes or mitochondrial detoxifying enzymes.

Conclusions:

• PPAR-γ inhibition leads to impaired catalase activity and reduced antioxidant defenses in astrocytes.
• A hypofunction of PPAR-γ may contribute to neurodegenerative mechanisms through peroxisomal damage.
• These findings establish a model for studying compounds that can restore peroxisomal function.